Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-05 Sale | 2024-04-09 4:22 pm | Cara Therapeutics Inc. | CARA | Goncalves Joana CHIEF MEDICAL OFFICER | 2,753 | $0.83 | $2,285 | 53,365 (Direct) | View |
| 2024-04-05 Sale | 2024-04-09 4:21 pm | Cara Therapeutics Inc. | CARA | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. | 2,753 | $0.83 | $2,285 | 88,247 (Direct) | View |
| 2024-02-29 Sale | 2024-03-04 4:24 pm | Cara Therapeutics Inc. | CARA | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. | 3,293 | $0.89 | $2,931 | 91,000 (Direct) | View |
| 2024-02-29 Sale | 2024-03-04 4:19 pm | Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO | 5,834 | $0.89 | $5,192 | 180,521 (Direct) | View |
| 2024-02-29 Sale | 2024-03-04 4:13 pm | Cara Therapeutics Inc. | CARA | Goncalves Joana CHIEF MEDICAL OFFICER | 3,293 | $0.89 | $2,931 | 56,118 (Direct) | View |
| 2023-02-08 Sale | 2024-02-12 5:16 pm | Cara Therapeutics Inc. | CARA | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. | 7,770 | $0.53 | $4,118 | 94,293 (Direct) | View |
| 2023-02-08 Sale | 2024-02-12 5:15 pm | Cara Therapeutics Inc. | CARA | Maynard Ryan D CHIEF FINANCIAL OFFICER | 5,488 | $0.53 | $2,909 | 8,012 (Direct) | View |
| 2023-02-08 Sale | 2024-02-12 5:13 pm | Cara Therapeutics Inc. | CARA | Goncalves Joana CHIEF MEDICAL OFFICER | 7,770 | $0.53 | $4,118 | 59,411 (Direct) | View |
| 2024-02-08 Sale | 2024-02-12 5:10 pm | Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO | 35,575 | $0.53 | $18,855 | 186,355 (Direct) | View |
| 2024-02-01 Sale | 2024-02-05 4:26 pm | Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO | 4,981 | $0.55 | $2,740 | 221,930 (Direct) | View |
| 2023-11-02 Sale | 2023-11-03 4:37 pm | Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO | 3,796 | $1.22 | $4,631 | 164,411 (Direct) | View |
| 2023-08-03 Sale | 2023-08-04 5:21 pm | Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO | 4,307 | $3.07 | $13,222 | 168,207 (Direct) | View |
| 2023-06-23 Sale | 2023-06-27 4:09 pm | Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. | 2,483 | $3.51 | $8,715 | 88,563 (Direct) | View |
| 2023-06-23 Sale | 2023-06-27 4:08 pm | Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | 2,993 | $3.51 | $10,505 | 153,747 (Direct) | View |
| 2023-06-23 Sale | 2023-06-27 4:07 pm | Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer | 2,723 | $3.51 | $9,558 | 53,681 (Direct) | View |
| 2023-05-05 Sale | 2023-05-09 4:22 pm | Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO | 3,869 | $4.4 | $17,024 | 172,514 (Direct) | View |
| 2023-04-04 Sale | 2023-04-06 5:14 pm | Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. | 2,481 | $4.91 | $12,182 | 91,046 (Direct) | View |
| 2023-04-04 Sale | 2023-04-06 5:13 pm | Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer | 2,481 | $4.91 | $12,182 | 56,404 (Direct) | View |
| 2023-04-04 Sale | 2023-04-06 5:12 pm | Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | 2,733 | $4.91 | $13,419 | 156,740 (Direct) | View |
| 2023-03-03 Sale | 2023-03-07 4:47 pm | Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO | 5,987 | $9.71 | $58,134 | 176,383 (Direct) | View |
| 2023-03-03 Sale | 2023-03-07 4:46 pm | Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | 6,802 | $9.71 | $66,047 | 159,473 (Direct) | View |
| 2023-03-03 Sale | 2023-03-07 4:44 pm | Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. | 6,256 | $9.71 | $60,746 | 93,527 (Direct) | View |
| 2023-03-03 Sale | 2023-03-07 4:43 pm | Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer | 6,221 | $9.71 | $60,406 | 58,885 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-01 Option Award | 2024-02-05 4:34 pm | N/A N/A | Cara Therapeutics Inc. | CARA | Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C. | 13,500 | $0 | 102,063 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:32 pm | N/A N/A | Cara Therapeutics Inc. | CARA | Maynard Ryan D CHIEF FINANCIAL OFFICER | 13,500 | $0 | 13,500 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:30 pm | N/A N/A | Cara Therapeutics Inc. | CARA | Goncalves Joana CHIEF MEDICAL OFFICER | 13,500 | $0 | 67,181 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:28 pm | N/A N/A | Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. CHIEF SCIENTIFIC OFF,SVP-R&D | 13,500 | $0 | 167,247 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:26 pm | N/A N/A | Cara Therapeutics Inc. | CARA | Posner Christopher PRESIDENT AND CEO | 62,500 | $0 | 221,930 (Direct) | View |
| 2023-08-02 Option Award | 2023-08-04 5:20 pm | N/A 2033-08-02 | Cara Therapeutics Inc. | CARA | Boudreau Helen M Director | 155,747 | $0 | 155,747 (Direct) | View |
Ownership | 2023-07-25 4:13 pm | N/A N/A | Cara Therapeutics Inc. | CARA | CSL LTD 10% Owner | 0 | $0 | 7,396,770 (Indirect) | View |
| 2023-06-01 Option Award | 2023-06-05 4:36 pm | N/A 2033-06-01 | Cara Therapeutics Inc. | CARA | von Moltke Lisa Director | 77,323 | $0 | 77,323 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:34 pm | N/A 2033-06-01 | Cara Therapeutics Inc. | CARA | Shiff Susan Ph.D. Director | 77,323 | $0 | 96,399 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:33 pm | N/A 2033-06-01 | Cara Therapeutics Inc. | CARA | Ives Jeffrey L. Director | 77,323 | $0 | 92,799 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:31 pm | N/A 2033-06-01 | Cara Therapeutics Inc. | CARA | BAINS HARRISON M JR Director | 77,323 | $0 | 102,399 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:29 pm | N/A 2033-06-01 | Cara Therapeutics Inc. | CARA | VOGELBAUM MARTIN Director | 154,647 | $0 | 199,635 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:38 pm | N/A 2033-03-01 | Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. | 81,000 | $0 | 81,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:38 pm | N/A 2033-03-01 | Cara Therapeutics Inc. | CARA | Maynard Ryan D Chief Financial Officer | 81,000 | $0 | 81,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:37 pm | N/A 2033-03-01 | Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer | 81,000 | $0 | 81,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:36 pm | N/A 2033-03-01 | Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | 81,000 | $0 | 81,000 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:35 pm | N/A 2033-03-01 | Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO | 250,000 | $0 | 250,000 (Direct) | View |